September 2, 2010 – New research released this week is the first to find both anatomical and procedural considerations that can lead to the creation of esophageal ulcerations (ESUL) after radiofrequency ablation of atrial fibrillation (AF).

September 2, 2010 - Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin therapy, according to new research.

September 1, 2010 - The world’s first zero footprint, client-free PACS, has received the highest performance score, 93.4 out of 100, in a recent survey conducted by KLAS, an independent monitor of the quality and customer acceptance of commercially-available healthcare information technology products.

September 1, 2010 – The European Society of Cardiology (ESC) upgraded fractional flow reserve (FFR) to a class I, level of evidence A, the highest class and level possible. The guidelines for FFR-guided treatment were included in the updated Guidelines on Percutaneous Coronary Intervention (PCI) announced Monday at the ESC congress in Stockholm.

September 1, 2010 - Z-Medica Corp., announced that it has signed an exclusive distribution agreement with Nihon-Kohden, Japan's manufacturer, developer and distributor of medical electronic equipment. The agreement allows Nihon-Kohden the exclusive right to distribute Z-Medica’s QuikClot line of hemostatic agents to hospital, military and law enforcement markets throughout Japan.